ArticleBMC plant biology2026
Genome-wide identification of MYB transcription factors in Rheum officinale Baill. and their responses to UV-B and MeJA treatment.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundRheum officinale Baill., a foundational plant in traditional Chinese medicine, whose roots and rhizomes exhibit significant pharmacological activities primarily attributed to anthraquinones and other bioactive compounds. However, the transcriptional regulatory mechanisms underlying anthraquinone biosynthesis are not well understood, and the key regulatory factors require further investigation. MYB transcription factors play central roles in secondary metabolism and stress signaling, suggesting their potential involvement in anthraquinone regulation, particularly in response to environmental cues such as UV-B radiation and hormonal signals like methyl jasmonate (MeJA).
resultsWe performed a genome-wide identification of MYB genes in R. officinale, identifying 237 RoMYBs, including 150 R2R3-MYBs, 81 R1-MYBs, four 3R-MYBs, and two atypical members. Phylogenetic, structural, and evolutionary analyses revealed conserved subfamily organization and gene family expansion driven primarily by segmental duplication. Notably, UV-B treatment significantly induced the accumulation of several anthraquinones, including rhein and emodin, in a time-dependent manner. Expression profiling identified RoMYBs responsive to both MeJA and UV-B, with RoMYB128 and RoMYB134 showing consistent upregulation that correlated with anthraquinone accumulation. Co-expression analysis further revealed that these two genes strongly correlated with multiple CHS-related structural genes in the anthraquinone biosynthetic pathway. Subcellular localization analysis confirmed nuclear localization of both proteins, and transcriptional activity assays revealed that RoMYB128 functions as a transcriptional activator.
conclusionsThis study provides the first comprehensive genomic overview of the MYB family in R. officinale and highlights candidate regulators that integrate light and hormone signaling to modulate anthraquinone biosynthesis, thereby offering a foundation for future mechanistic studies and metabolic engineering efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.